Cargando…

Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats

Background and Objectives: Side effects of anti-cancer drugs are usually accompanied by oxidative stress, including myelotoxicity. We evaluated the potential of oral highly activated micro-/macroporous carbon adsorbents (bulk density of 0.16 g/cm(3), surface area calculation by Brunauer–Emmett–Telle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shevchuk, Oksana, Snezhkova, Elisaveta, Sarnatskaya, Veronika, Mikhailenko, Victor, Glavin, Alexei, Makovetska, Lyudmyla, Bardakhivska, Kvitoslava, Birchenko, Inna, Kozynchenko, Oleksandr, Nikolaev, Volodymyr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780921/ https://www.ncbi.nlm.nih.gov/pubmed/31480729 http://dx.doi.org/10.3390/medicina55090557

Ejemplares similares

The effect of two formulations of carbon enterosorbents on oxidative stress indexes and molecular conformation of serum albumin in experimental animals exposed to CCl(4)
por: Sarnatskaya, Veronika, et al.
Publicado: (2020)

Myeloprotection with activated carbon in doxorubicin-treated rats
por: Gerashchenko, Bogdan I., et al.
Publicado: (2023)

Chemical modification of melphalan as a key to improving treatment of haematological malignancies
por: Gajek, Arkadiusz, et al.
Publicado: (2020)

Enterosorbents in complex therapy of food allergies: a focus on digestive disorders and systemic toxicity in children
por: Shichkin, Valentin P., et al.
Publicado: (2023)

COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review)
por: Krynytska, Inna, et al.
Publicado: (2021)

Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs
por: Howell, Carol A., et al.
Publicado: (2019)

Activated Carbon/Pectin Composite Enterosorbent for Human Protection from Intoxication with Xenobiotics Pb(II) and Sodium Diclofenac
por: Jandosov, Jakpar, et al.
Publicado: (2022)

Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.
por: McElwain, T. J., et al.
Publicado: (1979)

High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.
por: Benedetti Panici, P., et al.
Publicado: (1997)

Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.
por: Moscow, J. A., et al.
Publicado: (1993)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
por: Lee, Se Ryeon, et al.
Publicado: (2019)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
por: Ge, Qunfang, et al.
Publicado: (2022)

Retracted: Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The effect of systemic hyperthermia on melphalan pharmacokinetics in mice.
por: Honess, D. J., et al.
Publicado: (1985)

The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
por: Hinchliffe, M., et al.
Publicado: (1983)

Oral Melphalan Therapy in Advanced Malignant Disease
por: Clifford, Peter, et al.
Publicado: (1963)

Nitric oxide enhancement of melphalan-induced cytotoxicity.
por: Cook, J. A., et al.
Publicado: (1997)

Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
por: Shah, Nisha V., et al.
Publicado: (2014)

Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma
por: Yousef, Yacoub A., et al.
Publicado: (2020)

Intravitreal melphalan for persistent retinoblastoma vitreous seeds
por: Redondo-Villanueva, Marie Jeazelle H., et al.
Publicado: (2022)

Toxicity to intravitreal melphalan in a patient with retinoblastoma
por: Solaz-Ruiz, Marta Gema, et al.
Publicado: (2023)

HAEMATOLOGY IN TROPICAL AREAS: CLINICS IN HAEMATOLOGY
Publicado: (1983)

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Rodriguez, Tulio E., et al.
Publicado: (2016)

Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
por: Byun, Ja Min, et al.
Publicado: (2018)

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial
por: Farag, Sarah, et al.
Publicado: (2022)

Haematology /
por: Linch, David C.
Publicado: (1996)

Haematology
por: Cawley, John C
Publicado: (1983)

Hæmatology
Publicado: (1924)

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Response of two mouse tumours to hyperthermia with CCNU or melphalan.
por: Joiner, M. C., et al.
Publicado: (1982)

Repeat administration of high dose melphalan in relapsed myeloma.
por: Mansi, J. L., et al.
Publicado: (1993)

Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
por: Ji, Xunda, et al.
Publicado: (2016)

Melphalan modifies the bone microenvironment by enhancing osteoclast formation
por: Chai, Ryan C., et al.
Publicado: (2017)

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
por: Xue, Kang, et al.
Publicado: (2019)

Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma
por: Hsieh, Terry, et al.
Publicado: (2020)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
por: Byrgazov, Konstantin, et al.
Publicado: (2021)

Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction
por: Jorge, Rodrigo, et al.
Publicado: (2022)

The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
por: Gkotzamanidou, Maria, et al.
Publicado: (2022)

The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism
por: Kozak, Kateryna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmavuq73u5q5tsbmueu32bfiq3